![Seventure Partners announces the trade sale of its portfolio company Cambrooke Therapeutics, Inc. to Ajinomoto Co. Inc](https://www.seventure.fr/wp-content/uploads/2016/11/4__104270789-1-322x211.jpg)
10 November 2017
Seventure Partners announces the trade sale of its portfolio company Cambrooke Therapeutics, Inc. to Ajinomoto Co. Inc
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in the venture investment in the microbiome sector, today announces the trade sale of...